AI Threat Assessment · 26 May 2026

Brainsight AI

Neurotech
COOKED
6.7/ 10

“Brainsight built genuinely sophisticated TMS navigation software that neuroscientists and clinicians actually use — real IP, real regulatory approvals, real brain mapping that took a decade to get right. The cruel irony is that they've spent all that time becoming the world's best specialists in precisely guiding magnetic pulses to brain coordinates, just as AI started reading brain signals directly and rendering the whole 'where to zap' question charmingly analog.”

Business Model
7.5
Automation Risk
6.0
Moat Strength
4.5
Adaptability
7.0
Need Survival
7.5
AI Threat Level
BUSINESS MODEL REPLACEABILITY

Their value prop was 'we know exactly where to place the TMS coil for optimal brain stimulation' — a beautiful fusion of neuroscience and spatial precision that justified enterprise software pricing. Then Neuralink started reading intentions directly from neural signals, and suddenly the most sophisticated targeting system in the world looks like a very expensive way to knock on a door that AI just learned to unlock.

7.5
WORKFORCE AUTOMATION RISK

The neuroscientists who map brain regions and calibrate stimulation protocols aren't going anywhere soon — this is still PhD-level human expertise territory. The software engineers writing the navigation algorithms, however, are watching their precision-targeting code get outflanked by pattern recognition that doesn't need coordinates at all.

6.0
MOAT STRENGTH

FDA approval for medical devices is the kind of regulatory moat that usually means something — years of clinical trials, safety data, institutional adoption that doesn't switch on a whim. The problem is that the moat protects a castle built for artillery when the war just went nuclear.

4.5
AI ADAPTABILITY SIGNALS

Their recent product updates still focus on improving spatial precision and targeting accuracy — impressive engineering that solves yesterday's constraint while tomorrow's solution reads the brain like a book and skips the geography lesson entirely.

7.0
WILL THE NEED SURVIVE AI?

Brain stimulation therapy survives; the question 'where exactly should we stimulate?' doesn't. AI eliminates the targeting problem by replacing external stimulation with direct neural interface — it's not about better aim, it's about not needing to shoot at all.

7.5
Verdict

“Direct brain-computer interfaces don't compete with Brainsight — they make the entire category of 'external brain targeting' look like performing surgery through a telescope. The FDA approvals and clinical relationships buy them a few years while hospitals figure out that the most precise external brain tool ever built just became the most sophisticated obsolete technology in neuroscience.”

Scores are based on public information and AI analysis. This is an affectionate roast, not a financial assessment. The best companies use this as a mirror, not a verdict.

Roast another →